Laboratory of Molecular Pharmacology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.
Laboratory of Neurochemistry and Cellular Biology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.
Int J Environ Res Public Health. 2023 Feb 27;20(5):4207. doi: 10.3390/ijerph20054207.
The COVID-19 pandemic affected billions of people worldwide, and exposure to toxic metals has emerged as an important risk factor for COVID-19 severity. Mercury is currently ranked as the third toxic substance of global concern for human health, and its emissions to the atmosphere have increased globally. Both COVID-19 and mercury exposure present a high prevalence in similar regions: East and Southeast Asia, South America and Sub-Saharan Africa. Since both factors represent a multiorgan threat, a possible synergism could be exacerbating health injuries. Here, we discuss key aspects in mercury intoxication and SARS-CoV-2 infection, describing the similarities shared in clinical manifestations (especially neurological and cardiovascular outcomes), molecular mechanisms (with a hypothesis in the renin-angiotensin system) and genetic susceptibility (mainly by apolipoprotein E, paraoxonase 1 and glutathione family genes). Literature gaps on epidemiological data are also highlighted, considering the coincident prevalence. Furthermore, based on the most recent evidence, we justify and propose a case study of the vulnerable populations of the Brazilian Amazon. An understanding of the possible adverse synergism between these two factors is crucial and urgent for developing future strategies for reducing disparities between developed and underdeveloped/developing countries and the proper management of their vulnerable populations, particularly considering the long-term sequelae of COVID-19.
新冠疫情影响了全球数十亿人,而接触有毒金属已成为新冠严重程度的一个重要风险因素。汞目前被列为对人类健康全球关注的第三大有毒物质,其在全球的排放量有所增加。新冠疫情和汞暴露在相似的地区都有很高的流行率:东亚和东南亚、南美洲和撒哈拉以南非洲。由于这两个因素都代表着多器官的威胁,因此可能存在协同作用,从而加剧健康损伤。在这里,我们讨论了汞中毒和 SARS-CoV-2 感染的关键方面,描述了它们在临床表现(特别是神经和心血管结果)、分子机制(在肾素-血管紧张素系统中有一个假说)和遗传易感性(主要由载脂蛋白 E、对氧磷酶 1 和谷胱甘肽家族基因)方面的相似之处。还强调了流行病学数据方面的文献差距,考虑到它们的同时流行率。此外,根据最新的证据,我们为巴西亚马逊地区的弱势人群提出了一个案例研究。了解这两个因素之间可能存在的不利协同作用对于制定未来的策略以减少发达国家和欠发达国家/发展中国家之间的差距以及对其弱势人群进行妥善管理至关重要,特别是考虑到新冠长期的后遗症。